Synthesis and conclusion.
Fiche publication
Date publication
décembre 2012
Lien Pubmed
Résumé
It is well established that cancer increases the risk of venous thrombosis. Conversely, the mechanisms involved in haemostasis play a major role in the tumour development, facilitating tumour proliferation and altering the microenvironment, with major consequences in terms of the metastatic process. It is therefore mandatory to take the measure of this double bond between cancer and haemostasis. The clinicianwill be aware that venous thromboembolism is difficult to diagnose in cancer patients. At all stages of care, preventive and curativemeasures will be implemented, based on current recommendations and, if applicable, the standards which have been developed. With the French Group Thrombosis and Cancer (GFTC), a dynamics has been boosted in order to implement "RCP-thrombose".
Référence
Oncologie. 2012 Dec;14(12):667-70.